178462 Apolipoprotein C-II, Human Plasma, Very Low-Density Lipoprotein

178462
  
Retrieving price...
Price could not be retrieved
Minimum Quantity needs to be mulitiple of
Upon Order Completion More Information
You Saved ()
 
Request Pricing
Limited AvailabilityLimited Availability
Stocked 
Discontinued
Limited Quantities Available
Available
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

       

      Contact Customer Service

      Overview

      Replacement Information
      Description
      OverviewNative apolipoprotein C-II from human plasma. Found primarily in VLDL and chylomicrons. Functions as a cofactor for lipoprotein lipase. Elevated serum levels of Apo C-II are common in type I, III, IV, and V hyperlipoproteinemia. Low serum concentrations of Apo C-II are indicative of nephrotic syndrome (Tangier’s Disease).
      Catalogue Number178462
      Brand Family Calbiochem®
      SynonymsApo C-II
      References
      ReferencesBrunzell, J.D. 1989. in The Metabolic Basis of Inherited Disease, 6th Edition (Scriver, G.R., ed.) p. 1165, McGraw Hill, New York.
      Le, N.A., et al. 1988. J. Lipid Res. 29, 669.
      Jackson, R.L., and Holdsworth, G. 1986. Methods Enzymol. 128, Chapter 14.
      Product Information
      FormLyophilized
      FormulationLyophilized from 10 mM NH₄HCO₃, pH 7.4.
      Applications
      Biological Information
      Purity≥95% by SDS-PAGE
      SourcePrepared from plasma that has been shown by certified tests to be negative for HBsAg and for antibodies to HIV and HCV.
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage -20°C
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications

      Documentation

      Apolipoprotein C-II, Human Plasma, Very Low-Density Lipoprotein SDS

      Title

      Safety Data Sheet (SDS) 

      Apolipoprotein C-II, Human Plasma, Very Low-Density Lipoprotein Certificates of Analysis

      TitleLot Number
      178462

      References

      Reference overview
      Brunzell, J.D. 1989. in The Metabolic Basis of Inherited Disease, 6th Edition (Scriver, G.R., ed.) p. 1165, McGraw Hill, New York.
      Le, N.A., et al. 1988. J. Lipid Res. 29, 669.
      Jackson, R.L., and Holdsworth, G. 1986. Methods Enzymol. 128, Chapter 14.
      Data Sheet

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision15-April-2008 RFH
      SynonymsApo C-II
      DescriptionNative apolipoprotein C-II from human plasma. Found primarily in VLDL and chylomicrons. Functions as a cofactor of lipoprotein lipase. Elevated serum levels of Apo C-II are often present in type I, III, IV and V hyperlipoproteinemia. Low serum concentrations of Apo C-II are indicative of nephrotic syndrome (Tangier disease).
      FormLyophilized
      FormulationLyophilized from 10 mM NH₄HCO₃, pH 7.4.
      SourcePrepared from plasma that has been shown by certified tests to be negative for HBsAg and for antibodies to HIV and HCV.
      Purity≥95% by SDS-PAGE
      SolubilityH₂O. Please refer to vial label for lot-specific volume prior to lyophilization.
      Storage -20°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Standard Handling
      ReferencesBrunzell, J.D. 1989. in The Metabolic Basis of Inherited Disease, 6th Edition (Scriver, G.R., ed.) p. 1165, McGraw Hill, New York.
      Le, N.A., et al. 1988. J. Lipid Res. 29, 669.
      Jackson, R.L., and Holdsworth, G. 1986. Methods Enzymol. 128, Chapter 14.